Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Gerretsen

Showing results (151-160 of 196) with videos related to

Pageof 20
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|July 7, 2023
GWAS of biological aging to find longevity genes in schizophreniaJessica Qian, Corinne Fischer, Amer Burhan, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2018
BASIS: The blood pressure awareness and insight scalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Schizophrenia Bulletin|July 30, 2015
Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical TrialShinichiro Nakajima, Hiroyuki Uchida, Robert R Bies, et al.
Primary Care Diabetes|May 13, 2018
Reprint of OASIS - Obesity Awareness and Insight ScalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Obesity Medicine|December 4, 2018
OASIS: The Obesity Awareness and Insight ScalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Journal of Psychopharmacology (Oxford, England)|January 18, 2018
Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementiaSimon Jc Davies, Amer M Burhan, Donna Kim, et al.
Psychiatry Research. Neuroimaging|February 8, 2018
Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability studyEric Plitman, Sofia Chavez, Shinichiro Nakajima, et al.
Journal of Psychiatric Research|March 15, 2020
Glutamatergic neurometabolites and cortical thickness in treatment-resistant schizophrenia: Implications for glutamate-mediated excitotoxicityParita Shah, Eric Plitman, Yusuke Iwata, et al.
Schizophrenia Research|June 6, 2024
The effect of second-generation antipsychotics on anxiety/depression in patients with schizophrenia: A systematic review and meta-analysisAli Abdolizadeh, Maryam Hosseini Kupaei, Yasaman Kambari, et al.
Schizophrenia (Heidelberg, Germany)|January 10, 2025
Impaired insight in schizophrenia is associated with higher frontoparietal cerebral blood flow: an arterial spin labeling studyJianmeng Song, Edgardo Carmona-Torres, Yasaman Kambari, et al.
Pageof 20

Showing results (151-160 of 196) with videos related to

Sort By:
Pageof 20
European Archives of Psychiatry and Clinical Neuroscience|July 7, 2023
GWAS of biological aging to find longevity genes in schizophreniaJessica Qian, Corinne Fischer, Amer Burhan, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2018
BASIS: The blood pressure awareness and insight scalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Schizophrenia Bulletin|July 30, 2015
Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable With Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical TrialShinichiro Nakajima, Hiroyuki Uchida, Robert R Bies, et al.
Primary Care Diabetes|May 13, 2018
Reprint of OASIS - Obesity Awareness and Insight ScalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Obesity Medicine|December 4, 2018
OASIS: The Obesity Awareness and Insight ScalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Journal of Psychopharmacology (Oxford, England)|January 18, 2018
Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementiaSimon Jc Davies, Amer M Burhan, Donna Kim, et al.
Psychiatry Research. Neuroimaging|February 8, 2018
Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability studyEric Plitman, Sofia Chavez, Shinichiro Nakajima, et al.
Journal of Psychiatric Research|March 15, 2020
Glutamatergic neurometabolites and cortical thickness in treatment-resistant schizophrenia: Implications for glutamate-mediated excitotoxicityParita Shah, Eric Plitman, Yusuke Iwata, et al.
Schizophrenia Research|June 6, 2024
The effect of second-generation antipsychotics on anxiety/depression in patients with schizophrenia: A systematic review and meta-analysisAli Abdolizadeh, Maryam Hosseini Kupaei, Yasaman Kambari, et al.
Schizophrenia (Heidelberg, Germany)|January 10, 2025
Impaired insight in schizophrenia is associated with higher frontoparietal cerebral blood flow: an arterial spin labeling studyJianmeng Song, Edgardo Carmona-Torres, Yasaman Kambari, et al.
Pageof 20